$165.76-4.56 (-2.68%)
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.
ICON Public Limited Company in the Healthcare sector is trading at $165.76 with a market capitalization of $13.3B. Wall Street consensus targets $181.81 (16 analysts), implying a +9.7% move over the next 12 months. The stock is currently 19% below its 52-week high of $203.91, remaining 11.5% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.03B↓ | $2.19B↑ | $2.08B↑ | $2.02B↑ | $2.02B |
| Gross Profit | $477.93M↓ | $500.89M↓ | $545.46M↓ | $561.60M↓ | $566.06M |
| Operating Income | $187.00M↓ | $230.37M↓ | $249.38M↓ | $258.88M↓ | $271.72M |
| Net Income | $104.75M↑ | -$110.14M↑ | -$284.18M↓ | $182.97M↑ | $160.81M |
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, ma...
Icon PLC (ICLR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
City Different Investments, an investment management firm, released Q2 2026 investor update for its global equity strategies. A copy of the letter can be downloaded here. City Different global equity strategies delivered strong results in the second quarter, but trailed the global market driven by AI enthusiasm. Its Focused Global returned +7.08%, and Global Equity […]
ICON stock sits at an unusual valuation crossroads, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to a 33.2% discount while earnings-based multiples indicate the shares look expensive relative to fundamentals, all against a three-year share price record that is still in decline. ICON shareholders have seen the stock decline 31.9% over the past three years, which keeps recent gains in context and may explain why some investors are focused on whether current pricing...
Artisan Partners, an investment management firm, issued its first-quarter 2026 investor letter for the “Artisan Mid Cap Value Fund”. A copy of this letter is available for download here. In Q1 2026, the portfolio underperformed the benchmark Russell Midcap Value Index as the market favored momentum-driven stocks over quality factors. Some holdings faced company-specific setbacks and […]
Icon (ICLR) has reestablished a "credible" path to mid-single-digit organic growth in 2027 after two